Robert J. Hombach's Net Worth

$7.59 Million

Estimate Recalculated Sep 17, 2024 04:55PM EST

Who is Robert J. Hombach?

Robert J. Hombach has an estimated net worth of $7.59 Million. This is based on reported shares across multiple companies, which include BAXTER INTERNATIONAL INC, Embecta Corp., BIOMARIN PHARMACEUTICAL INC, CARMAX INC, Baxalta Inc, and Aptinyx Inc..

SEC CIK

Robert J. Hombach's CIK is 0001496182

Past Insider Trading and Trends

2013 was Robert J. Hombach's most active year for acquiring shares with 18 total transactions. Robert J. Hombach's most active month to acquire stocks was the month of June. 2016 was Robert J. Hombach's most active year for disposing of shares, totalling 10 transactions. Robert J. Hombach's most active month to dispose stocks was the month of May. 2013 saw Robert J. Hombach paying a total of $2,523,739.90 for 191,740 shares, this is the most they've acquired in one year. In 2013 Robert J. Hombach cashed out on 50,533 shares for a total of $3,721,664.12, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BAXTER INTERNATIONAL INC (BAX) Snapshot price: $38.96

Corporate Vice President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+27.65%
17.54K
—
—
80.97K
Mar 3
Form 4
+15.07%
8.31K
—
—
63.43K
Feb 16
Form 4
+280.49%
40K
—
—
54.26K
Jun 2
Form 4
—
0
—
—
0
Mar 4
Form 4
+64.82%
5.61K
$68.40
-$67,305.60
14.26K
Jan 29
Form 4
-20.06%
-2.53K
$69.54
-$175,936.20
10.08K
Sep 3
Form 4
—
0
$63.57
-$985,335.50
12.61K
Scheduled
Jul 22
Form 4
—
0
—
—
0
Mar 5
Form 4
+9.84%
1.12K
$66.52
-$36,652.52
12.53K
Jan 16
Form 4
—
0
—
—
0
Mar 6
Form 4
—
0
—
—
0
Mar 4
Form 4
+6.05%
1.16K
$50.30
-$31,085.40
20.29K
Jan 19
Form 4
+35.54%
5K
—
—
19.07K
Sep 1
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Embecta Corp. (EMBC) Snapshot price: $15.31

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+85.17%
11.46K
—
—
24.9K
Feb 7
Form 4
+114.49%
6.98K
—
—
13.07K
Feb 9
Form 4
∞
6.02K
—
—
6.02K
Apr 1
Form 3
—
0
—
—
0
No matching records found

BIOMARIN PHARMACEUTICAL INC (BMRN) Snapshot price: $83.7

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+15.48%
4.72K
—
—
35.22K
May 21
Form 4
+15.93%
4.19K
—
—
30.5K
May 23
Form 4
+23.35%
4.98K
—
—
26.31K
May 24
Form 4
+31.59%
5.12K
—
—
21.33K
May 25
Form 4
+36.10%
4.3K
—
—
16.21K
May 27
Form 4
+59.22%
4.43K
—
—
11.91K
Jun 4
Form 4
+135.22%
4.3K
—
—
7.48K
Jun 5
Form 4
∞
3.18K
—
—
3.18K
Sep 29
Form 3
—
0
—
—
0
No matching records found

CARMAX INC (KMX) Snapshot price: $79.8

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+20.25%
1.31K
—
—
7.77K
Jul 2
Form 4
+45.55%
2.02K
—
—
6.46K
Jun 26
Form 4
+83.57%
2.02K
—
—
4.44K
Jun 28
Form 4
+8,851.85%
2.39K
—
—
2.42K
Jun 29
Form 3
—
0
—
—
0
No matching records found

Baxalta Inc No price found

EVP. CFO and COO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-192.73K
—
—
0
Jun 3
Form 4
+64.53%
75.48K
$39.30
-$231,870.00
192.46K
Mar 3
Form 4
+2.53%
2.89K
$39.00
-$158,574.00
116.98K
Feb 15
Form 4
+1.70%
1.89K
—
—
113.45K
Aug 11
Form 4
∞
111.56K
—
—
111.56K
Jul 1
Form 3
—
0
—
—
0
No matching records found